Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

OBJECTIVE: This study evaluated the cost-effectiveness of apatinib in patients with chemotherapy-refractory mGC. PATIENTS AND METHODS: A Markov model was developed to simulate the clinical course of typical patients with chemotherapy-refractory metastatic gastric cancer (mGC). We estimated the 10-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yongrui, Xu, Yuejuan, Wu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727640/
https://www.ncbi.nlm.nih.gov/pubmed/29317864
http://dx.doi.org/10.1155/2017/2816737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727640/
https://www.ncbi.nlm.nih.gov/pubmed/29317864
http://dx.doi.org/10.1155/2017/2816737

Ejemplares similares